Literature DB >> 11764306

Standard treatment: the role of antihistamines.

H F Merk1.   

Abstract

Histamine-1 (H1) antihistamines are the first-line drug for the treatment of urticaria. Major progress has been achieved in recent years both in the understanding of their ligands, the H1-histamine receptors, and therefore in the mechanisms of their pharmacologic effects, as well as in the development of safer antihistamines with low or no sedating effects and no interactions on the level of potassium channels leading to QT-prolongations and interactions on the level of cytochrome P450 isoenzymes. This development has brought antihistamines very close to the ideal antihistamines that are desired by clinicians to treat most types of urticaria in patients who have to take these drugs for a long time.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11764306     DOI: 10.1046/j.0022-202x.2001.00032.x

Source DB:  PubMed          Journal:  J Investig Dermatol Symp Proc        ISSN: 1087-0024


  2 in total

1.  Management of chronic urticaria in Asia: 2010 AADV consensus guidelines.

Authors:  Steven K W Chow
Journal:  Asia Pac Allergy       Date:  2012-04-30

2.  A TRPV2-PKA signaling module for transduction of physical stimuli in mast cells.

Authors:  Alexander J Stokes; Lori M N Shimoda; Murielle Koblan-Huberson; Chaker N Adra; Helen Turner
Journal:  J Exp Med       Date:  2004-07-12       Impact factor: 14.307

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.